Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |